Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2023-10-01
2023-12-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions on the positioning actions are:
* their actions impact of positioning actions on shear forces
* their impact on sliding in the chair
* their impact on the feeling of discomfort in the chair
* their impact on the caregivers' feelings about the patient's difficulties (eating, transfers, sliding)
Participation in this study will involve an increase in the number of transfers required for shear sheet placement and removal, as well as the time required for ischial measurement and the time to complete the (Tool for Assessing Wheelchair disComfort) TAWC questionnaire.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Wheelchair Positioning and Neuromuscular Diseases
NCT05006859
Wheelchair Positioning and Pain in Neuromuscular Patients
NCT02141724
Effects of an Early Wheelchair Reconditionong Program on Functional Independence in Spinal Cord-inured Individuals
NCT01105260
Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor
NCT04335942
Elaboration of a Pronostic Score of Changes on Wheelchair's Seating System
NCT05785546
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All patients meeting the study eligibility criteria
Choice and adjustment of the wheelchair according to the patient's needs
After a personalized analysis of the patient and his needs, the occupational therapists define the equipment necessary for the good positioning of the patient:
* Choice and adjustments of the wheelchair
* Choice and adjustments of the wheelchair/patient interface
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Choice and adjustment of the wheelchair according to the patient's needs
After a personalized analysis of the patient and his needs, the occupational therapists define the equipment necessary for the good positioning of the patient:
* Choice and adjustments of the wheelchair
* Choice and adjustments of the wheelchair/patient interface
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient aged between 18 and 80 years,
* Patient with a sitting time in a wheelchair \> or equal to 1 hour,
* Patient with a neurological condition : multiple sclerosis, stroke, spinal cord injury, Parkinson disease, neurodegenerative diseases...
* Patient informed of the study and having given his written consent,
* Cognitive disorders that do not allow the understanding of instructions
* Patient with a pressure sore
* Pregnant or breastfeeding woman
* Patient under legal protection
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GHICL
UNKNOWN
FondationbHopale
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean Gabriel PREVINAIRE, MD
Role: PRINCIPAL_INVESTIGATOR
Fondation Hopale
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Julien PAGER
Berck, Hauts-de-France, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HOP-RIPH2-21-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.